3 assets in Luminal A Breast Carcinoma

Therapeutic assets addressing Luminal A Breast Carcinoma, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Goserelin Luminal A Breast Carcinoma	University Hospital, Akershus	P2	B (57)
Letrozole Luminal A Breast Carcinoma	University Hospital, Akershus	P2	B (57)
Ribociclib Luminal A Breast Carcinoma	University Hospital, Akershus	P2	B (57)